A Phase I Study to Assess the Safety of Pegcetacoplan (APL-2) as an Add-On to Standard of Care in Subjects With PNH

Name: A Phase I Study to Assess the Safety of Pegcetacoplan (APL-2) as an Add-On to Standard of Care in Subjects With PNH
Published: 2015
License: Public Domain

Apellis Pharmaceuticals, Inc. · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

anemia

paroxysmal nocturnal hemoglobinuria (pnh), pnh, paroxysmal nocturnal hemoglobinuria, complement inhibitor, anemia, hemoglobinuria, hematologic diseases, extravascular hemolysis (evh), intravascular hemolysis (ivh), c3 inhibitor, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Phase I Study to Assess the Safety of Pegcetacoplan (APL-2) as an Add-On to Standard of Care in Subjects With PNH

Related documents